Cargando…
Monitoring of molecular profiling of allergen-antibody responses in HDM-immunotherapy patients
Among the potential hazards of HDM immunotherapy (AIT) with HDM allergenic extracts is the possible initiation of de novosensitizations caused by a lack of complementarity between a given HDM vaccine’s content and a patient’s molecular sensitization profile. To investigate whether immunotherapy with...
Autores principales: | Nittner-Marszalska, Marita, Kopeć, Agnieszka, Foks-Ciekalska, Aleksandra, Lata, Aleksandra, Bogacz- Piaseczyńska, Agnieszka, Rosiek-Biegus, Marta, Zajac, Magdalena, Bożek, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762793/ https://www.ncbi.nlm.nih.gov/pubmed/36444880 http://dx.doi.org/10.1080/21645515.2022.2148815 |
Ejemplares similares
-
Long-term benefit after allergen immunotherapy to HDM in elderly patients with allergic rhinitis
por: Bożek, Andrzej, et al.
Publicado: (2023) -
Pfizer-BioNTech COVID-19 Vaccine Tolerance in Allergic versus Non-Allergic Individuals
por: Nittner-Marszalska, Marita, et al.
Publicado: (2021) -
Component-Resolved Evaluation of the Risk and Success of Immunotherapy in Bee Venom Allergic Patients
por: Rosiek-Biegus, Marta, et al.
Publicado: (2022) -
The Effectiveness of Allergen Immunotherapy in Adult Patients with Atopic Dermatitis Allergic to House Dust Mites
por: Bogacz-Piaseczyńska, Agnieszka, et al.
Publicado: (2022) -
Adding a biologic to allergen immunotherapy increases treatment efficacy
por: Bożek, Andrzej, et al.
Publicado: (2023)